ZA902662B - Pyridine derivatives - Google Patents
Pyridine derivativesInfo
- Publication number
- ZA902662B ZA902662B ZA902662A ZA902662A ZA902662B ZA 902662 B ZA902662 B ZA 902662B ZA 902662 A ZA902662 A ZA 902662A ZA 902662 A ZA902662 A ZA 902662A ZA 902662 B ZA902662 B ZA 902662B
- Authority
- ZA
- South Africa
- Prior art keywords
- pyridine derivatives
- formula
- agonists
- antihypertensives
- heteroaromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898907865A GB8907865D0 (en) | 1989-04-07 | 1989-04-07 | Tetrahydroquinoline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA902662B true ZA902662B (en) | 1991-02-27 |
Family
ID=10654625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA902662A ZA902662B (en) | 1989-04-07 | 1990-04-05 | Pyridine derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5075303A (xx) |
| EP (1) | EP0395244B1 (xx) |
| JP (1) | JP2945064B2 (xx) |
| KR (1) | KR0156569B1 (xx) |
| AT (1) | ATE149031T1 (xx) |
| AU (1) | AU625845B2 (xx) |
| CA (1) | CA2014062C (xx) |
| DD (1) | DD298391A5 (xx) |
| DE (1) | DE69029954T2 (xx) |
| DK (1) | DK0395244T3 (xx) |
| ES (1) | ES2099703T3 (xx) |
| FI (1) | FI95373C (xx) |
| GB (2) | GB8907865D0 (xx) |
| GR (1) | GR3023396T3 (xx) |
| HK (1) | HK121994A (xx) |
| HU (1) | HU217128B (xx) |
| IE (1) | IE63627B1 (xx) |
| IL (1) | IL94011A (xx) |
| NZ (1) | NZ233222A (xx) |
| PH (1) | PH27590A (xx) |
| PT (1) | PT93673B (xx) |
| ZA (1) | ZA902662B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2660657B1 (fr) * | 1990-04-09 | 1993-05-07 | Adir | Nouveaux derives du 3-aminochromane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US5273994A (en) * | 1990-04-09 | 1993-12-28 | Adir Et Compagnie | 3-aminochroman compounds |
| GB9019942D0 (en) * | 1990-09-12 | 1990-10-24 | Wyeth John & Brother Ltd | Azetidine derivatives |
| US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
| GB9304632D0 (en) * | 1993-03-06 | 1993-04-21 | Wyeth John & Brother Ltd | Amide derivatives |
| JPH09510695A (ja) * | 1994-01-03 | 1997-10-28 | エイシア・ファーマシュウティカルズ，インコーポレイテッド | ８−アザ、６−アザ、および６，８−ジアザ−１，４−ジヒドロキノキサリン−２，３−ジオン類およびそのグリシン／ｎｍｄａリセプターに対するアンタゴニストとしての使用 |
| US5609849A (en) * | 1994-03-11 | 1997-03-11 | The Trustees Of The University Of Pennsylvania | Serotonin (5-HT1A) receptor ligands and imaging agents |
| US6180632B1 (en) * | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| US7105513B2 (en) * | 2002-08-07 | 2006-09-12 | Sanofi-Avertis Deutschland Gmbh | Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
| US8426590B2 (en) * | 2009-03-23 | 2013-04-23 | Cipla Limited | Process for the preparation of doxazosin and salts thereof |
| US9266840B2 (en) * | 2011-10-18 | 2016-02-23 | Astellas Pharma Inc. | Bicyclic heterocyclic compound |
| EP3126451B1 (en) * | 2014-04-01 | 2020-09-09 | Howard Hughes Medical Institute | Azetidine-substituted fluorescent compounds |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH566315A5 (xx) * | 1972-04-04 | 1975-09-15 | Ciba Geigy Ag | |
| GB1463582A (en) * | 1974-03-05 | 1977-02-02 | Wyeth John & Brother Ltd | Pyridine derivatives |
| GB1463583A (en) * | 1974-03-05 | 1977-02-02 | Wyeth John & Brother Ltd | Halo and hydroxy compounds |
| DK309678A (da) * | 1977-07-18 | 1979-01-19 | Sandoz Ag | Fremgangsmaade til fremstilling af tetralinderivater |
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| DK111387A (da) * | 1986-03-05 | 1987-09-06 | Otsuka Pharma Co Ltd | Carbostyrilderivater og salte deraf, laegemiddel indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne |
| US4748182A (en) * | 1986-03-05 | 1988-05-31 | Merrell Dow Pharmaceuticals Inc. | Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents |
| JPS63107990A (ja) * | 1986-05-14 | 1988-05-12 | Nippon Shinyaku Co Ltd | キノリンカルボン酸誘導体 |
| DE3718317A1 (de) * | 1986-12-10 | 1988-06-16 | Bayer Ag | Substituierte basische 2-aminotetraline |
| DE3719924A1 (de) * | 1986-12-22 | 1988-06-30 | Bayer Ag | 8-substituierte 2-aminotetraline |
| US4894084A (en) * | 1987-12-29 | 1990-01-16 | Fmc Corporation | Substituted quinolinonyl and dihydroquinolinonyl triazolinone herbicides |
| US4878941A (en) * | 1987-12-29 | 1989-11-07 | Fmc Corporation | Herbicides |
-
1989
- 1989-04-07 GB GB898907865A patent/GB8907865D0/en active Pending
-
1990
- 1990-04-05 AU AU52971/90A patent/AU625845B2/en not_active Ceased
- 1990-04-05 PT PT93673A patent/PT93673B/pt not_active IP Right Cessation
- 1990-04-05 ZA ZA902662A patent/ZA902662B/xx unknown
- 1990-04-05 IL IL9401190A patent/IL94011A/en not_active IP Right Cessation
- 1990-04-05 NZ NZ233222A patent/NZ233222A/en unknown
- 1990-04-06 JP JP2092961A patent/JP2945064B2/ja not_active Expired - Fee Related
- 1990-04-06 US US07/505,957 patent/US5075303A/en not_active Expired - Lifetime
- 1990-04-06 DK DK90303708.3T patent/DK0395244T3/da active
- 1990-04-06 HU HU902108A patent/HU217128B/hu not_active IP Right Cessation
- 1990-04-06 KR KR1019900004697A patent/KR0156569B1/ko not_active IP Right Cessation
- 1990-04-06 GB GB9007889A patent/GB2230007B/en not_active Expired - Fee Related
- 1990-04-06 DE DE69029954T patent/DE69029954T2/de not_active Expired - Fee Related
- 1990-04-06 DD DD90339534A patent/DD298391A5/de unknown
- 1990-04-06 PH PH40345A patent/PH27590A/en unknown
- 1990-04-06 IE IE125290A patent/IE63627B1/en not_active IP Right Cessation
- 1990-04-06 EP EP90303708A patent/EP0395244B1/en not_active Expired - Lifetime
- 1990-04-06 AT AT90303708T patent/ATE149031T1/de not_active IP Right Cessation
- 1990-04-06 CA CA002014062A patent/CA2014062C/en not_active Expired - Fee Related
- 1990-04-06 ES ES90303708T patent/ES2099703T3/es not_active Expired - Lifetime
- 1990-04-06 FI FI901761A patent/FI95373C/fi not_active IP Right Cessation
-
1994
- 1994-11-03 HK HK121994A patent/HK121994A/xx not_active IP Right Cessation
-
1997
- 1997-05-09 GR GR970401050T patent/GR3023396T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US5075303A (en) | 1991-12-24 |
| GB2230007B (en) | 1992-10-14 |
| GR3023396T3 (en) | 1997-08-29 |
| DE69029954D1 (de) | 1997-03-27 |
| JPH02290852A (ja) | 1990-11-30 |
| HK121994A (en) | 1994-11-11 |
| NZ233222A (en) | 1991-07-26 |
| KR0156569B1 (ko) | 1998-11-16 |
| KR900016138A (ko) | 1990-11-12 |
| JP2945064B2 (ja) | 1999-09-06 |
| DE69029954T2 (de) | 1997-05-28 |
| HUT54658A (en) | 1991-03-28 |
| ATE149031T1 (de) | 1997-03-15 |
| IE63627B1 (en) | 1995-05-17 |
| AU5297190A (en) | 1990-10-11 |
| GB8907865D0 (en) | 1989-05-24 |
| EP0395244A1 (en) | 1990-10-31 |
| FI95373C (fi) | 1996-01-25 |
| DD298391A5 (de) | 1992-02-20 |
| IL94011A (en) | 1994-06-24 |
| PH27590A (en) | 1993-08-18 |
| HU217128B (hu) | 1999-11-29 |
| FI901761A0 (fi) | 1990-04-06 |
| CA2014062C (en) | 2000-06-13 |
| GB2230007A (en) | 1990-10-10 |
| EP0395244B1 (en) | 1997-02-19 |
| DK0395244T3 (da) | 1997-03-17 |
| FI95373B (fi) | 1995-10-13 |
| HU902108D0 (en) | 1990-08-28 |
| PT93673B (pt) | 1996-08-30 |
| PT93673A (pt) | 1990-11-20 |
| CA2014062A1 (en) | 1990-10-07 |
| AU625845B2 (en) | 1992-07-16 |
| GB9007889D0 (en) | 1990-06-06 |
| ES2099703T3 (es) | 1997-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5151423B1 (en) | Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use | |
| MA21778A1 (fr) | Procede d'obtention de derives de n - ( 3-hydroxy-4 piperidinyl ) dihydro-benzofuranne, dihydro-2h- ,benzopyranne ou dihydro benzodioxin ) carboxamide . | |
| ES2130116T3 (es) | Derivados de piperazina. | |
| GB2230007B (en) | Pyridine derivatives | |
| HUT59394A (en) | Process for producing piperazine derivatives and pharmaceutical compositions comprising same | |
| HU9300108D0 (en) | Pyridine derivatives | |
| ATE78154T1 (de) | Salz von 6-(1-piperidinyl-)2,4-diaminopyrimidin-3-oxyd und acetylaminoessigsaeure deren herstellung und deren dermatokosmetische verwendung. |